Sponsor content
335 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for WAINUA eplontersen (as sodium) 45 mg/0.8 mL solution for injection pre-filled pen.
-
Australian public assessment report (AusPar)Tezspire has been approved as an add-on maintenance treatment in patients aged 12 years and older with severe asthma who are inadequately controlled despite optimal therapy including medium or high dose inhaled corticosteroids plus another non-steroidal medicinal product.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SAPHNELO anifrolumab 120 mg (150 mg/mL) solution for injection in pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BREZTRI AEROSPHERE 160/7.2/5 budesonide 160 mcg/glycopyrronium 7.2 mcg/formoterol fumarate dihydrate 5 mcg per actuation inhalation pMDI (DFP-EvoCap).
-
-
Apr-2026Prescription medicine evaluationActive ingredient: trastuzumab deruxtecan.
-
Australian public assessment report (AusPar)Kavigale (sipavibart) has been approved for the pre-exposure prophylaxis of COVID-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who are immunocompromised due to a medical condition or receipt of immunosuppressive medications or treatments.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DAPAGLIFLOZIN AZN dapagliflozin (as propanediol monohydrate) 10 mg film-coated tablet blister pack.
-
Prescription medicine registrationActive ingredients: acalabrutinib maleate monohydrate.
-
Feb-2026Prescription medicine evaluationActive ingredient: baxdrostat.